Zydus Lifesciences' Stock Sees Decline, But Remains Strong in Pharma Industry
Zydus Lifesciences, a leading pharmaceutical company, has seen a decline in its stock performance with a -5.65% drop on August 26, 2024. Despite this, the company's moving averages are still higher than the 100 and 200 day averages. In comparison to the Sensex, Zydus Lifesciences' performance has been -5.08% in 1 day and -7.52% in 1 month. However, the company remains a strong player in the industry with consistent growth and market presence.
Zydus Lifesciences, a leading pharmaceutical company in the largecap industry, has recently faced a dip in its stock performance. On August 26, 2024, the company's stock saw a decline of -5.65%, underperforming the sector by -4.9%. This has led to a 'Strong Buy' call by MarketsMOJO for the stock.
The stock has been on a consecutive fall for the past two days, with a total decline of -7.54% in this period. It also opened with a gap down of -2.52% today and touched an intraday low of Rs 1109 (-5.91%). However, the stock's moving averages are still higher than the 100 day and 200 day averages, but lower than the 5 day, 20 day, and 50 day averages.
In comparison to the Sensex performance, Zydus Lifesciences' 1 day performance is -5.08%, while the Sensex saw a positive growth of 0.61%. Similarly, the company's 1 month performance is -7.52%, while the Sensex saw a growth of 0.30%.
Despite the recent dip in stock performance, Zydus Lifesciences remains a strong player in the pharma industry. With its consistent growth and strong market presence, the company continues to be a top choice for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
